greeksoup/ stock research
Stock research / United States / BNTX / Year to 31 December 2019

BioNTech SE (BNTX) annual results, year to 31 December 2019: revenue EUR 109 million, from the 20-F

BioNTech SE files a 20-F with the SEC once a year, in euros. In the year to 31 December 2019 it reported revenue of EUR 109 million ($122 million at the year's average rate), down 14.9% on the year before. Its profit attributable to shareholders was EUR -179 million, and diluted earnings per share EUR -0.85.

Revenue
EUR 109 million
-14.9% on the year
FY2017FY2019
Operating margin
-167.1%
-42.2% a year earlier
FY2017FY2019
Net income
EUR -179 million
FY2017FY2019
Diluted EPS
EUR -0.85
FY2017FY2019

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2018Dec 2019 †
Revenue128109
Cost of sales13.717.4
Gross profit11491.2
Research and development143226
Operating profit-53.9-182
Finance costs0.02.0
Profit before tax-47.7-179
Income tax0.6-0.2
Profit for the year-48.3-179
Profit attributable to shareholders-48.0-179
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2018Dec 2019 †
Diluted EPSn/a-0.85
Basic EPSn/a-0.85
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2018Dec 2019 †
Cash from operations-58.9-198
Purchase of property, plant and equipment29.938.6
Free cash flow-88.8-237
Cash from investing-66.5-77.2
Cash from financing365383
Depreciation and amortisation22.033.9
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2018Dec 2019 †
Funded by
Equity attributable to shareholders266493
Non-controlling interests0.8n/a
Borrowings, as filed0.074.2
Lease liabilities50.857.6
Other liabilities335172
Total equity and liabilities653798
Owned
Property, plant and equipment66.293.0
Goodwilln/a3.0
Cash and cash equivalents412519
Inventories5.811.7
Other assets169171
Total assets653798
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2018Dec 2019 †
Gross margin89.3%84.0%
Operating margin-42.2%-167.1%
Net margin-37.6%-164.9%
Free cash flow margin-69.6%-218.3%
Return on year-end equity-18.0%-36.3%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2019, filed 26 October 2022: the filing. The figures are in euros as filed.